Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis.

Carcinomas arising from epithelial cells represent the most prevalent malignancies in humans, and metastasis is the major cause for the death of carcinoma patients. The breakdown of epithelial cell homeostasis leading to aggressive cancer progression has been correlated with the loss of epithelial characteristics and the acquisition of a migratory phenotype. This phenomenon, referred to as epithelial to mesenchymal transition (EMT), is considered as a crucial event in late stage tumorigenesis. Here we summarize the multitude of EMT models derived from different tissues, and review the diversity of molecular mechanisms contributing to the plasticity of epithelial cells. In particular, the synergism between activation of Ras, provided by the aberrant stimulation of receptor tyrosine kinases, and transforming growth factor (TGF)-beta signaling plays a pivotal role in inducing EMT of various epithelial cell types. Cytokines such as TGF-beta and extracellular matrix molecules are thought to fundamentally contribute to the microenvironmental interaction between stromal and malignant cells, and provide the basis for a broad repertoire of epithelial differentiation. Investigations of EMT tumor models, which represent in vitro correlates to local invasion and metastasis in vivo, facilitate the identification of diagnostic markers for a more accurate and faithful clinical and pathological assessment of epithelial tumors. In addition, the analysis of molecular mechanisms involved in EMT might yield novel therapeutic targets for the specific treatment of aggressive carcinomas.

[1]  D. Bissell Chronic liver injury, TGF-β, and cancer , 2001, Experimental & Molecular Medicine.

[2]  C. Heldin,et al.  TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. , 1999, Journal of cell science.

[3]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[4]  S. Seki,et al.  Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis , 1995, The Lancet.

[5]  Keith E. Mostov,et al.  Building epithelial architecture: insights from three-dimensional culture models , 2002, Nature Reviews Molecular Cell Biology.

[6]  S. Vilaró,et al.  Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. , 1999, Journal of cell science.

[7]  T. Seufferlein,et al.  Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. , 2001, Cancer research.

[8]  D. Chopin,et al.  Epithelial Cell Plasticity in Development and Tumor Progression , 2004, Cancer and Metastasis Reviews.

[9]  R. Atkins,et al.  Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  R. Kalluri,et al.  Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. , 2002, Kidney international.

[11]  J. Jouanneau,et al.  Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line. , 1990, Cell regulation.

[12]  H. Beug,et al.  TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis , 1998, Current Biology.

[13]  W. Hahn,et al.  Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.

[14]  S. Vilaró,et al.  Epithelial‐mesenchymal transition of cultured rat neonatal hepatocytes is differentially regulated in response to epidermal growth factor and dimethyl sulfoxide , 1997, Hepatology.

[15]  S. Chi,et al.  Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. , 2000, Cancer research.

[16]  P. Savagner,et al.  Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[17]  E. Hay An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[18]  J. Zavadil,et al.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[20]  A. Kiemer,et al.  Identification of genes involved in epithelial-mesenchymal transition and tumor progression , 2001, Oncogene.

[21]  R. Reeves,et al.  Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells , 2001, Molecular and Cellular Biology.

[22]  B. Schaffhauser,et al.  Epithelial Mesenchymal Transition by C-Fos Estrogen Receptor Activation Involves Nuclear Translocation of β-Catenin and Upregulation of β-Catenin/Lymphoid Enhancer Binding Factor-1 Transcriptional Activity , 2000, The Journal of cell biology.

[23]  Z. Werb,et al.  Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to-Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial Cells , 1997, The Journal of cell biology.

[24]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[25]  J. Thiery,et al.  Alternative patterns of mitogenesis and cell scattering induced by acidic FGF as a function of cell density in a rat bladder carcinoma cell line. , 1990, Cell regulation.

[26]  C. Arteaga,et al.  p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. , 2002, Journal of cell science.

[27]  M J Bissell,et al.  The influence of the microenvironment on the malignant phenotype. , 2000, Molecular medicine today.

[28]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[29]  R. Schulte‐Hermann,et al.  Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. , 2002, Journal of cell science.

[30]  M. Nieto,et al.  A New Role for E12/E47 in the Repression ofE-cadherin Expression and Epithelial-Mesenchymal Transitions* , 2001, The Journal of Biological Chemistry.

[31]  G. Bratthauer,et al.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.

[32]  A. Balmain,et al.  Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[33]  L. Ellis,et al.  Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. , 2001, Archives of surgery.

[34]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[35]  A. Ridley,et al.  Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. , 1998, Molecular biology of the cell.

[36]  O. Dietze,et al.  Co‐expression of tenascin‐C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins , 2001, The Journal of pathology.

[37]  M. Mareel,et al.  Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[38]  H. Beug,et al.  TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. , 1996, Genes & development.

[39]  S. Dedhar,et al.  Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. , 2001, Journal of cell science.

[40]  E. Sahai,et al.  RHO–GTPases and cancer , 2002, Nature Reviews Cancer.

[41]  H. Schwarz,et al.  The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions , 1996, The Journal of cell biology.

[42]  S. Friedman,et al.  Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy , 1999, Journal of gastroenterology and hepatology.

[43]  C. Der,et al.  Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.

[44]  R. Kalluri,et al.  Early role of Fsp1 in epithelial-mesenchymal transformation. , 1997, American journal of physiology. Renal physiology.

[45]  S. Dedhar,et al.  Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase , 1996, Nature.

[46]  Y. Zheng,et al.  Rac1 and extracellularly regulated kinase activation are sufficient for E1A-dependent cooperative transformation of primary epithelial cells, but progression can only be modulated by E1A or Rac1. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[47]  L. Peso,et al.  The Ras family of GTPases in cancer cell invasion , 2000, Cellular and Molecular Life Sciences CMLS.

[48]  F. Spagnoli,et al.  Inhibition of MMH (Met murine hepatocyte) cell differentiation by TGF(beta) is abrogated by pre-treatment with the heritable differentiation effector FGF1. , 2000, Journal of cell science.

[49]  H. Moses,et al.  Integrin (cid:1) 1 Signaling Is Necessary for Transforming Growth Factor- (cid:1) Activation of p38MAPK and Epithelial Plasticity* , 2022 .

[50]  M. Sporn The war on cancer , 1996, The Lancet.

[51]  S. Kawata,et al.  Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. , 1991, Cancer research.

[52]  Kenneth M. Yamada,et al.  The Zinc-Finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor–induced Epithelial–Mesenchymal Transition , 1997, The Journal of cell biology.

[53]  S. Friedman,et al.  Liver fibrosis -- from bench to bedside. , 2003, Journal of hepatology.

[54]  H. Sheng,et al.  Transforming Growth Factor-β1 Promotes Invasiveness after Cellular Transformation with Activated Ras in Intestinal Epithelial Cells , 2001 .

[55]  M. Reichert,et al.  The PDZ Domains of Zonula Occludens-1 Induce an Epithelial to Mesenchymal Transition of Madin-Darby Canine Kidney I Cells , 2000, The Journal of Biological Chemistry.

[56]  J. Thiery,et al.  Modulations of the epithelial phenotype during embryogenesis and cancer progression. , 1994, Cancer treatment and research.

[57]  G. Christofori,et al.  The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. , 1999, Trends in biochemical sciences.

[58]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[59]  A. Balmain,et al.  Metastasis is driven by sequential elevation of H-ras and Smad2 levels , 2002, Nature Cell Biology.

[60]  M. Bissell,et al.  The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion , 2001, Breast Cancer Research.

[61]  T. Carey,et al.  Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion , 1996, The Journal of cell biology.

[62]  Avri Ben-Ze'ev,et al.  The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.

[63]  Allan Balmain,et al.  TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.

[64]  G. Adler,et al.  Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. , 2001, Cancer research.

[65]  Kozo Kaibuchi,et al.  Rho-family GTPases in cadherin-mediated cell — cell adhesion , 2001, Nature Reviews Molecular Cell Biology.

[66]  H. Band,et al.  Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion. , 2000, Molecular biology of the cell.

[67]  C. Caulin,et al.  Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[68]  B. Boyer,et al.  Induction and regulation of epithelial-mesenchymal transitions. , 2000, Biochemical pharmacology.

[69]  Ying E. Zhang,et al.  TGF‐β receptor‐activated p38 MAP kinase mediates Smad‐independent TGF‐β responses , 2002 .

[70]  J. Thiery,et al.  Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. , 2002, Journal of cell science.

[71]  L. Matrisian,et al.  Loss of JunB Activity Enhances Stromelysin 1 Expression in a Model of the Epithelial-to-Mesenchymal Transition of Mouse Skin Tumors , 2001, Molecular and Cellular Biology.

[72]  L. Wakefield,et al.  TGF-β signaling: positive and negative effects on tumorigenesis , 2002 .

[73]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[74]  S. Roche,et al.  Src and Ras are involved in separate pathways in epithelial cell scattering , 1997, The EMBO journal.

[75]  A. Ridley Rho GTPases and cell migration. , 2001, Journal of cell science.

[76]  A. Schulze,et al.  Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. , 2000, Genes & development.

[77]  E. Hafen,et al.  Ras--a versatile cellular switch. , 1998, Current opinion in genetics & development.

[78]  H. Schwarz,et al.  Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion , 1992, Cell.

[79]  M. P. Quinlan,et al.  The C terminus of E1A regulates tumor progression and epithelial cell differentiation. , 1998, Virology.

[80]  L. Matrisian,et al.  Tumor progression: Defining the soil round the tumor seed , 2001, Current Biology.

[81]  D. Riethmacher,et al.  Factors controlling growth, motility, and morphogenesis of normal and malignant epithelial cells. , 1995, International review of cytology.

[82]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[83]  H. Moses,et al.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.

[84]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[85]  A. M. Arias Epithelial Mesenchymal Interactions in Cancer and Development , 2001, Cell.

[86]  M. Bissell,et al.  The tumor-promoting effect of wounding: a possible role for TGF-beta-induced stromal alterations. , 1994, Critical reviews in oncogenesis.

[87]  K. Sass,et al.  N-Cadherin Extracellular Repeat 4 Mediates Epithelial to Mesenchymal Transition and Increased Motility , 2000, The Journal of cell biology.

[88]  J. Downward,et al.  Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis , 2002, The Journal of Cell Biology.

[89]  Véronique Delmas,et al.  IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition , 2001, Oncogene.

[90]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[91]  H. Moses,et al.  Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.